Screener
Pacific Biosciences of California PACB Income Tax
Discontinued — last reported Q2 '26
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
| (In thousands, except per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest expense | (2,110) | (1,738) | (3,850) | (3,475) |
| Other income, net | 2,037 | 4,696 | 4,043 | 8,990 |
| Loss before income taxes | (44,683) | (41,895) | (52,774) | (468,272) |
| Income tax provision (benefit) | 58 | 35 | 242 | (267) |
| Net loss | (44,741) | (41,930) | (53,016) | (468,005) |
| Other comprehensive loss: | ||||
| Unrealized loss on investments | (356) | (114) | (960) | (155) |
| Comprehensive loss | $(45,097) | $(42,044) | $(53,976) | $(468,160) |
Item 1. Financial Statements (unaudited):
FAQ
- What is Pacific Biosciences of California's income tax?
- Pacific Biosciences of California (PACB) reported income tax of $58K in Q2 2026.
- How has Pacific Biosciences of California's income tax changed year-over-year?
- Pacific Biosciences of California's income tax increased by 65.7% year-over-year, from $35K to $58K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Pacific Biosciences of California's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude